109 related articles for article (PubMed ID: 3171883)
1. A radioimmunoassay for MC-838 (altiopril calcium), a novel angiotensin-converting enzyme inhibitor.
Hinohara Y; Tanaka S; Wakabayashi K
J Pharmacobiodyn; 1988 Jun; 11(6):411-5. PubMed ID: 3171883
[TBL] [Abstract][Full Text] [Related]
2. Antihypertensive action of a novel orally active angiotensin converting enzyme inhibitor altiopril calcium (MC-838) in several hypertensive models of rats: comparison with captopril.
Aono J; Koga T; Yamazaki T; Shiraki Y; Sakai K
Arch Int Pharmacodyn Ther; 1988; 292():203-22. PubMed ID: 3293542
[TBL] [Abstract][Full Text] [Related]
3. Tissue angiotensin-converting enzyme blockade by MC-838 (altiopril calcium) infused intravenously to miniature pigs: comparison with captopril.
Sakai K; Shiraki Y; Akima M; Imagawa J; Hinohara Y; Koga T; Ichihara T; Tohira Y
Arch Int Pharmacodyn Ther; 1988; 294():228-40. PubMed ID: 2852930
[TBL] [Abstract][Full Text] [Related]
4. Chronotropic and inotropic effects of a new angiotensin converting enzyme inhibitor, MC-838 (altiopril calcium), on the dog heart.
Chiba S; Furukawa Y; Saegusa K; Ohba Y
Jpn Heart J; 1988 Nov; 29(6):841-8. PubMed ID: 3241337
[TBL] [Abstract][Full Text] [Related]
5. MC-838 (altiopril calcium): a novel orally active angiotensin converting enzyme inhibitor.
Sakai K; Aono J; Shiraki Y; Hinohara Y; Akamatsu A; Tanaka S; Kuromaru K
Tohoku J Exp Med; 1987 Aug; 152(4):363-74. PubMed ID: 3660405
[TBL] [Abstract][Full Text] [Related]
6. Comparative cardiovascular effects of a novel angiotensin converting enzyme inhibitor altiopril calcium (MC-838) and captopril in spontaneously hypertensive rats.
Akima M; Shiraki Y; Sakai K
Arch Int Pharmacodyn Ther; 1988; 292():223-36. PubMed ID: 3293543
[TBL] [Abstract][Full Text] [Related]
7. Contribution of the tissue angiotensin converting enzyme to the antihypertensive effect of altiopril calcium (MC-838) in spontaneously hypertensive rats.
Kamei K; Shiraki Y; Koga T; Sakai K
J Pharm Pharmacol; 1989 Apr; 41(4):279-80. PubMed ID: 2568474
[TBL] [Abstract][Full Text] [Related]
8. Radioimmunoassay for imidapril, a new angiotensin-converting enzyme inhibitor, and imidaprilat, its active metabolite, in human plasma and urine.
Yamanaka K; Morikawa S; Murata K; Banno K; Sato T; Takai T; Suzuki T; Mizobe M; Ito M; Ishibashi K
J Pharm Biomed Anal; 1996 Jan; 14(3):281-7. PubMed ID: 8851752
[TBL] [Abstract][Full Text] [Related]
9. A radioimmunoassay for SQ 27,519, the active phosphinic acid-carboxylic diacid of the prodrug fosinopril in human serum.
Tu JI; Brennan J; Stouffer B; Eckelman WC
Ther Drug Monit; 1990 Jul; 12(4):404-10. PubMed ID: 2144379
[TBL] [Abstract][Full Text] [Related]
10. Comparison of acute hemodynamic effects of MC-838, a new angiotensin-converting enzyme inhibitor, with captopril in anesthetized dogs.
Noguchi K; Kato T; Sunagawa R; Miyamoto Y; Sakanashi M
Jpn J Pharmacol; 1986 Mar; 40(3):373-80. PubMed ID: 3012164
[TBL] [Abstract][Full Text] [Related]
11. A radioimmunoassay for the angiotensin converting enzyme inhibitor ramipril and its active metabolite.
Eckert HG; Münscher G; Oekonomopulos R; Strecker H; Urbach H; Wissmann H
Arzneimittelforschung; 1985; 35(8):1251-6. PubMed ID: 3000393
[TBL] [Abstract][Full Text] [Related]
12. A new radioimmunoassay for the determination of the angiotensin-converting enzyme inhibitor perindopril and its active metabolite in plasma and urine: advantages of a lysine derivative as immunogen to improve the assay specificity.
van den Berg H; Resplandy G; de Bie AT; Floor W; Bertrand M; Arts CJ
J Pharm Biomed Anal; 1991; 9(7):517-24. PubMed ID: 1817672
[TBL] [Abstract][Full Text] [Related]
13. Uptake of N-[1 (S)-carboxy-(4-OH-3-125I-phenyl)ethyl]-L-Ala-L-Pro, an inhibitor of angiotensin-converting enzyme by rabbit lungs in situ.
Turrin M; Pitt BR; Ryan JW; Chung AY; Clark MB; Gillis CN
J Pharmacol Exp Ther; 1986 Jul; 238(1):14-8. PubMed ID: 3014113
[TBL] [Abstract][Full Text] [Related]
14. Radioimmunoassay for ceronapril, a new angiotensin-converting enzyme inhibitor, and its application to a pharmacokinetic study in healthy male volunteers.
Tu JI; Brennan J; Stouffer B; Mantha S; Turabi N; Tsay HM
Ther Drug Monit; 1992 Jun; 14(3):209-19. PubMed ID: 1412607
[TBL] [Abstract][Full Text] [Related]
15. Radioimmunoassay for the quantitation of lisinopril and enalaprilat.
Worland PJ; Jarrott B
J Pharm Sci; 1986 May; 75(5):512-6. PubMed ID: 3016233
[TBL] [Abstract][Full Text] [Related]
16. Radioimmunoassays for a new angiotensin-converting enzyme inhibitor, zabicipril, and its active metabolite, zabiciprilat, in human plasma.
Lelievre E; Cardona H; Brillanceau MH; Piraube C; Sauveur C
J Pharm Sci; 1992 Nov; 81(11):1065-70. PubMed ID: 1447705
[TBL] [Abstract][Full Text] [Related]
17. Enzyme immunoassays for a new angiotensin-converting enzyme inhibitor, zabicipril, and its active metabolite in human plasma: application to pharmacokinetic studies.
Ezan E; Morge X; Lelièvre E; Créminon C; Piraube C; Grognet JM
Ther Drug Monit; 1993 Oct; 15(5):448-54. PubMed ID: 8249053
[TBL] [Abstract][Full Text] [Related]
18. Competitive inhibitor binding assay (IBA) of captopril and other inhibitors of angiotensin converting enzyme.
Tikkanen FF; Grönhagen-Riska C
Scand J Urol Nephrol Suppl; 1984; 79():13-6. PubMed ID: 6089313
[TBL] [Abstract][Full Text] [Related]
19. Enzyme immunoassay of the active metabolite (RS-5139) of angiotensin converting enzyme inhibitor (CS-622).
Shioya H; Shimojo M; Kawahara Y
J Immunoassay; 1991; 12(1):15-28. PubMed ID: 2040710
[TBL] [Abstract][Full Text] [Related]
20. N alpha-(diphenoxyphosphoryl)-L-alanyl-L-proline, N alpha-[bis (4-nitrophenoxy)phosphoryl]-L-alanyl-L-proline, and N alpha-[ (2-phenylethyl)phenoxyphosphoryl]-L-alanyl-L-proline: releasers of potent inhibitors of angiotensin converting enzyme at physiological pH and temperature.
Galardy RE; Grobelny D
J Med Chem; 1985 Oct; 28(10):1422-7. PubMed ID: 2995664
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
